All News HansBiomed Corporation

Equities

A042520

KR7042520007

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
13,490 ^KRW	+7.06%		+2.98%	-8.11%

Feb. 14	HansBiomed Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	CI
2023	HansBiomed Corporation(KOSDAQ:A042520) added to S&P Global BMI Index	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HansBiomed Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 14	CI
HansBiomed Corporation(KOSDAQ:A042520) added to S&P Global BMI Index	23-09-18	CI
HansBiomed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-15	CI
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.	22-12-23	CI
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.	22-12-23	CI
HansBiomed Corporation's Equity Buyback announced on June 23, 2022, has expired with 202,283 shares, representing 2.08% for KRW 1,986.65 million.	22-12-22	CI
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.	22-09-22	CI
HansBiomed Corporation(KOSDAQ:A042520) dropped from S&P Global BMI Index	22-09-19	CI
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.	22-07-18	CI
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.	22-07-18	CI
HansBiomed Corporation's Equity Buyback announced on January 17, 2022, has expired with 246,000 shares, representing 2.46% for KRW 2,962.2 million.	22-07-17	CI
HansBiomed Corporation announces an Equity Buyback for KRW 2,000 million worth of its shares.	22-06-22	CI
HansBiomed Corporation authorizes a Buyback Plan.	22-06-22	CI
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.	22-04-17	CI
HansBiomed Corporation announces an Equity Buyback for KRW 3,000 million worth of its shares.	22-01-17	CI
HansBiomed Corporation authorizes a Buyback Plan.	22-01-16	CI
HansBiomed Corporation Auditor Raises 'Going Concern' Doubt	21-12-20	CI
HansBiomed Corporation announced that it has received KRW 15 billion in funding from Noh & Partners Corporation	21-10-25	CI
Rebirth Biotechnology Co., Ltd announced that it has received CNY 20 million in funding from HansBiomed Corporation	21-09-23	CI
Rebirth Biotechnology Co., Ltd announced that it expects to receive CNY 20 million in funding from HansBiomed Corporation	21-08-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News HansBiomed Corporation

Equities

A042520

KR7042520007

All News

Filters